date,title,source
Oct-22-18,Corvus Pharmaceuticals Announces New Data on Adenosine Gene Signature Biomarker Associated with Patient Response to CPI-444 at European Society for Medical Oncology (ESMO) 2018 Congress,GlobeNewswire
Nov-01-18,Corvus Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Business Update,GlobeNewswire
Nov-05-18,"Corvus Pharmaceuticals to Webcast Investor & Analyst Event on November 10, 2018",GlobeNewswire
Nov-12-18,Corvus Pharmaceuticals to Present at the 27th Annual Credit Suisse Healthcare Conference,GlobeNewswire
Nov-13-18,"Report: Exploring Fundamental Drivers Behind Berry Petroleum, Quotient, Virco Manufacturing, Corvus Pharmaceuticals, Marine Products, and Hamilton Beach Brands Holding  New Horizons, Emerging Trends, and Upcoming Developments",GlobeNewswire
Nov-23-18,Sarepta Stock More Than Doubles This Year So Far: Here's Why,Zacks
Dec-28-18,Ziopharm Oncology (ZIOP) in Focus: Stock Moves 6.2% Higher,Zacks
Jan-08-19,"Corvus Announces Enrollment in Second Arm of Phase 1/1b Dose-Escalation Trial of Anti-CD73 Antibody, CPI-006, Focused on Combination with CPI-444 Adenosine Antagonist",GlobeNewswire
